19.92%, respectively. The increase was due to the company and subsidiaries managed to control their selling and administrative expense well. Total expense compared to total revenue ratio decreased from

future cash flows, the terminal growth rate and discounted rate used in the assumptions are based on management of the subsidiary and indirect subsidiary’s judgment and past experience and business plan

promising growth was attributed by the increase of number of patients as well as bill amount per patient. A yoy slight decline of social security revenue were mainly from high care cost revenue following the

structure of the Company was in the strength level and cash flow could be managed effectively, hence, there was no interest paid. According to the above mentioned reasons, the Company’s profit before income

pandemic has affected Thai economy an early on February 2020, which likely cause a continued changing and dispersed forecast of the GDP growth in the year of 2020 as well as how and when the economic

asset as of March 31, 2020 with amount of 184.75 million bath decreased from Q1 of 2019 by 11.41 million bath or 5.82% decreased due to the main reason of the decreasing of cash and cash equivalents of

GDP growth in the year of 2020 as well as how and when the economic resumption would occur. Furthermore, the partial lockdown mandated in the last week of March 2020 resulted in a more pronounced

respect to the first 6-month period of 2019, the Company suffered a loss from its management due to lower revenues as well as higher selling expenses and administrative expenses in comparison with the

, and cash and cash equivalents of Baht 111.64 million. An increasing of assets mostly came from trade and other receivable increased by Baht 189.37 million, investment in associates increased by Baht

revenue growth. In addition, the increase of cash and cash equivalents due to profit of the Company. However, there was a decrease of investment held as available- for-sale by THB 41.91 Million due to